We can detect the ␤-globin gene sickle cell mutation by using an assay based on the ligase chain reaction. The simultaneous amplification of the human growth hormone gene in the same reaction serves as a control for the amount of template DNA or amplification efficiency. Ligation products, which are biotinylated at one end and tagged with an arbitrary "tail" sequence at the other, are captured by hybridization to "tail"-complementary oligonucleotides immobilized on polystyrene microwells. The captured ligation products are detected colorimetrically by use of streptavidin-alkaline phosphatase conjugate. In a study of 24 subjects, the assay unequivocally discriminated among normal, carrier, and sickle cell genotypes.
INDEXING TERMS: hemoglobinopathies • DNA amplification • genetic diseases • human growth hormone gene • biotin-streptavidin interaction Ligase chain reaction (LCR) and other ligation-based assays such as gap LCR and the oligonucleotide ligation assay have been used independently or coupled to the polymerase chain reaction to diagnose genetic and infectious diseases [1, 2] . 4 LCR is a DNA template-dependent amplification reaction that utilizes two pairs of oligonucleotides-one pair complementary to the upper template strand, and the other pair complementary to the lower template strand. Each member of a pair hybridizes to adjacent positions on the template such that the 5Ј-phosphate of one oligonucleotide abuts the 3Ј-hydroxyl of the other. The resulting nick is sealed by DNA ligase. The product of one round of ligation can serve as a template for a subsequent cycle; thus, using a thermostable ligase and performing sequential cycles of denaturation and ligation result in an exponential accumulation of product. Because a mismatch in the ligation junction inhibits the ligation reaction, LCR is ideal for the diagnosis of known mutations.
Sickle cell anemia is caused by a single-base mutation in the ␤-globin gene in which codon 6 is no longer GAG (producing Glu; normal or A allele) but instead is GTG (producing Val; S allele). The variant HbS polypeptide is routinely detected by electrophoretic and HPLC procedures [3, 4] . In newborns, detection of Hb variants at an initial screening is usually followed by confirmatory testing after several months, when the proportion of HbF has decreased. In some cases, the phenotypes or genotypes of other family members must be evaluated to reach an accurate diagnosis.
We have developed the Sickle Cell by LCR assay, a robust, colorimetric assay for typing A/A (normal), A/S (sickle cell carrier) and S/S (sickle cell disease-affected) subjects. DNA isolated from blood is tested for the presence of the A and S alleles. False negatives due to inadequate amount of starting DNA sample are readily identified by lack of coamplification of the human growth hormone (hGH) gene included in the same assay. The ligation products are detected in a 96-well microplate format. The high sequence-specificity of the LCR assay allows genotypic assignment based on the ratio of the A allele-specific signal to the S allele-specific signal.
Materials and Methods oligonucleotides
Oligonucleotides were purchased from Integrated DNA Technologies (Coralville, IA), Oligos Etc. (Wilsonville, OR), and Operon Technologies (Alameda, CA). Oligonucleotide sequences are given in Table 1 . The A allele oligonucleotide set comprises MD157, 159, 160, and 162; the S allele oligonucleotide set, MD159, 161, 162, and 166; and the hGH oligonucleotide set, MD111, 168, 169, and 170. All oligonucleotide modifications were performed by the respective vendors during synthesis. Oligonucleotides MD159 and MD111 were biotinylated by incorporating biotin-dT at the penultimate 3Ј-end position during synthesis. Oligonucleotides MD159, 162, 111, and 169 were chemically phosphorylated at the 5Ј-end by methods used by the vendor. We purified the LCR oligonucleotides by denaturing acrylamide gel electrophoresis [5] , then analyzed the purified LCR oligonucleotides on a second denaturing gel to confirm that they consisted of a single band. We determined oligonucleotide concentrations were determined by ultraviolet absorbance and by use of the molar absorptivities calculated for each oligonucleotide as described elsewhere [6] .
purified genomic dnas
Human placental DNA (presumptive A/A genotype) was purchased from Sigma, St. Louis, MO; cell line CRL8756 (S/S genotype) from the American Type Culture Collection, Rockville, MD; and cell lines GM08779 (A/S genotype) and GM02267 (homozygous deletion of the ␤-globin gene) from the NIGMS Human Genetic Mutant Cell Repository, Camden, NJ. We prepared genomic DNAs from the cell lines by using standard methods of phenol extraction/ethanol precipitation [5] or the A.S.A.P. genomic DNA isolation kit (Boehringer-Mannheim, Indianapolis, IN). Genomic DNA concentrations were determined by ultraviolet absorbance, with the assumption that 1 A 260 corresponds to 40 mg/L [5] .
blood samples
Whole-blood samples were collected from 24 adult subjects of known genotypes (8 A/A, 8 A/S, and 8 S/S) and anticoagulated with EDTA. DNA was isolated from the blood without delay (unless specified otherwise) by use of the InstaGene TM Whole Blood Kit (Bio-Rad Labs., Hercules, CA). For the precision and blood storage studies, we used blood collected as above from two homozygous A/A subjects. Blood samples from subjects with genotypes A/G San Jose , D/S, and S/C were collected at "V. Cervello" Hospital, Palermo, and at Istituti Clinici di Perfezionamento Laboratorio di Ricerche Cliniche, Milan. The presence of hemoglobin chain variants in all samples was confirmed by using the Bio-Rad Variant TM Hemoglobin Testing System [4] . Studies were conducted in accordance with the Helsinki Declaration and the guidelines for research at the H. San Raffaele Institute. ϩ , and 0.1 mL/L Triton X-100. In S allele-specific LCR, the A allele oligonucleotide set was replaced by the S allele oligonucleotide set (7.6 nmol/L of each oligonucleotide), and the concentration of each hGH oligonucleotide was decreased to 0.8 nmol/L. LCRs were performed in batches of eight patients' samples in a thermal cycler using the following program: 94°C for 1.5 min, followed by 55°C for 6 min (2 cycles), then 91°C for 0.5 min, followed by 55°C for 6 min (25 cycles). We included the following amplification controls with each batch of patients' samples assayed: 250 ng of human placental DNA, 250 ng of cell line CRL8756 DNA, and a blank (water added instead of DNA template).
Capture oligonucleotide immobilization. Oligonucleotides MD123 (specific for the ␤-globin A and S ligation products) and MD269 (specific for the hGH ligation product) were resuspended in 0.5 mol/L EDTA, pH 8, and immobilized in polystyrene wells (Maxisorp; Nunc, Naperville, IL) by passive adsorption [7, 8] . We added to each well 50 L of a 0.2 mol/L oligonucleotide solution, incubated the wells overnight at 37°C, and then washed them five times with Radias Well Wash buffer (Bio-Rad Labs.).
Colorimetric detection. After amplification, the A-specific and S-specific reaction mixtures were diluted 10-and 5-fold, respectively, with 1ϫ SSC (150 mmol/L NaCl and 15 mmol/L sodium citrate, pH 7). Separate 50-L aliquots of the diluted mixtures were loaded into MD123-or MD269-coated microwells and incubated at 37°C for 1 h; the wells were then washed five times with Radias Well Wash buffer. We diluted streptavidin-alkaline phosphatase conjugate (Bio-Rad Labs.) 1:4000 with 1ϫ SSC and added 50 L of the diluted conjugate to each well; after incubation at 37°C for 1 h, we washed the wells five times with Radias Well Wash buffer. Alkaline phosphatase was detected with a colorimetric amplification scheme based on (a) the initial conversion of NADPH (substrate) to NADH; (b) the subsequent interconversion of NADH to NAD ϩ in a cyclic redox reaction in the presence of alcohol dehydrogenase, diaphorase, and INT-violet (amplifier); and (c) the production of a formazan end product with A max at 490 nm [9] . Both substrate and amplifier for the colorimetric detection were from Bio-Rad Labs.
First, we added 50 L of substrate to each well; after 30 min at 37°C, 50 L of amplifier was added. The plate was immediately transferred to a Model 3550 microplate reader controlled by the Microplate Manager data analysis software (both from Bio-Rad Labs.). The rate of color formation was determined by taking A 490 readings every 20 s for 3 min. The detection controls consisted of the biotinylated oligonucleotides MD122 and MD117 (sequences not shown), which are complementary to the immobilized MD123 and MD269, respectively, and a detection blank (1ϫ SSC).
Results
With the proper design of LCR oligonucleotides, one can detect LCR amplification products in a nonradioactive, ELISA-like microplate format. In the approach described here, one of the four oligonucleotides is labeled with biotin and another oligonucleotide is tagged with an arbitrary "tail" sequence. These two oligonucleotides are complementary to the same strand of template DNA; ligation thus results in the formation of a molecule that has biotin at one end and a "tail" at the other. This molecule is captured by hybridization to a "tail"-complementary oligonucleotide immobilized on the surface of a microwell. The presence of biotin is detected by sequential reactions with streptavidin-alkaline phosphatase and a chromogenic substrate.
Each DNA sample is tested in two duplex LCRs: The A-specific reaction coamplifies the ␤-globin A allele and the hGH gene (the measured signals being henceforth referred to as A and hGH A , respectively), and the Sspecific reaction coamplifies the S allele and the hGH gene (giving signals S and hGH S , respectively). DNA ligase has been reported to join a perfectly matched junction with at least 10-fold greater efficiency than a mismatched ligation junction [10] [11] [12] . To assure unambiguous genotyping, we set up the following specifications for the LCR sickle cell assay: (a) The ratio of the specific signal to the nonspecific signal should be Ն10 (i.e., A:S signal ratio should be Ͼ10 for homozygous A/A and Ͻ0.1 for homozygous S/S), and (b) in a heterozygous A/S sample, the A and S signals should differ by a factor of 3 or less (0.3Ͻ A:S ratio Ͻ3).
Our investigations of LCR conditions-different oligonucleotide concentrations, ligase concentrations, cycling temperature setpoints, and cycle numbers-determined that the optimum assay conditions require the addition of twice as much S allele oligonucleotides as A allele oligonucleotides in the LCR, and the detection of twice as much S-specific as A-specific ligation products (see Materials and Methods).
To demonstrate the high allele-specificity of the LCR assay, we tested tissue and cell-line genomic DNAs of known genotypes. As shown in Fig. 1 , the A-specific reaction showed little cross-reactivity with the S allele, and vice versa. Moreover, the A:S signal ratios for the A/A, A/S, and S/S samples fell within the ranges specified. A sample containing a homozygous deletion of the ␤-globin gene gave A and S signals similar to those obtained for a blank (no DNA template added), indicating the absence of both alleles; in addition, the same sample was clearly differentiated from the blank by the hGH signal.
To evaluate the utility of the assay as a diagnostic tool, we assayed whole-blood samples collected from the 24 adult subjects of known genotypes. The genomic DNAs were prepared and duplicate aliquots of the DNA preparation were assayed by LCR. First, we used the hGH signal to assess whether enough DNA had been present for the LCR step for the assay to be valid. The hGH signal cutoff values were determined by running 20 blank Aspecific and 20 blank S-specific reactions (i.e., no DNA template added). The mean (ϮSD) values obtained were: hGH A 4.9 (Ϯ2.2) and hGH S 6.5 (Ϯ3.4) mA/min. Positive detection of the hGH gene was defined as hGH A Ͼ11.5 or hGH S Ͼ16.7, corresponding to signals Ͼ3 SD above the respective means of the blank values. All 48 DNA preparations in this set gave hGH values exceeding these limits.
As shown in Fig. 2 , the A:S signal ratios of the 24 patients' samples clearly correlated with genotype. The mean (ϮSD) A:S signal ratios obtained were 38.0 (Ϯ7.2) for A/A, 0.74 (Ϯ0.13) for A/S, and 0.03 (Ϯ0.004) for S/S. All ratios were within assay specifications.
The near-equivalence of the A and S signals in heterozygous A/S samples indicates that little or no interference occurred between the normal and S sequences in either the A-specific or S-specific LCRs. To determine whether this observation could be extended to other alleles, we tested four subjects with heterozygous genotypes (Table 2) . One sample repeatedly gave hGH signals below the cutoffs and was rejected. The results for the other three samples showed that the A-and S-specific LCRs were highly specific for their respective target alleles, even if another ␤-globin allele present in the sample differed by only a single base in the region amplified. Interestingly, the A:S signal ratios obtained for these samples were slightly different from those in Fig. 2 .
To determine the precision of the assay (in terms of the A:S signal ratio), we assayed blood from a single A/A patient collected on three different days, each day's blood sample being used to make eight replicate DNA preparations. The 24 LCR assays gave a mean A:S signal ratio (i.e., mean of daily means) of 46.9, with a within-run SD of 11.9 (CV 25%) and a total SD of 11.5 (CV 24%) [13] . In all cases, the A:S signal ratio was Ͼ10.
The validity of the LCR assay was determined by using blood that had been stored for various times (Fig. 3) . Blood from an A/A subject was stored in aliquots at 2-8°C for as long as 7 days before DNA isolation.
Similarly, blood from a second A/A subject was stored at Ϫ20°C for as long as 6 weeks. All DNA samples from the same subject were batched and tested in the LCR assay on the same day. All samples showed an A:S signal ratio Ͼ10, although imprecision for the aliquots stored at Ϫ20°C (mean ϭ 39.7, SD ϭ 13.5, CV ϭ 34%) was greater than for those stored at 2-8°C (mean ϭ 38.6, SD ϭ 4.0, CV ϭ 10%).
Discussion
In a study of 24 subjects, the Sickle Cell by LCR assay was able to discriminate among A/A, A/S, and S/S genotypes. Because the differences in A:S signal ratios among the three classes of patients were at least an order of magnitude, genotypic assignment was unambiguous. The use of a simple and fast DNA extraction procedure and a 96-well detection format means that results can be obtained in ϳ6 h after the whole blood is collected. The assay can also be performed with blood samples that have been refrigerated at 2-8°C for as long as 1 week or frozen at Ϫ20°C for as long as 6 weeks. The results presented here are for EDTA-anticoagulated blood samples. However, blood collected in citrate or heparin can also be used (data not shown). The target sequence in LCR is a very short region of the DNA preparations from 24 patients' blood samples were tested in duplicate by the LCR assay for sickle cell, and the average A:S signal ratios were plotted. Samples 1-8: A/A homozygotes; 9 -16, A/S heterozygotes; 17-24, S/S homozygotes. Fig. 3 . Effect of blood storage on LCR assay A:S signal ratios.
Blood samples collected from two A/A patients were stored at either 2-8°C (f) or Ϫ20°C (Ⅺ) for different periods before DNA preparation was performed.
gene complementary to the oligonucleotides used in the reaction. In LCR, the target is "queried" for the presence of perfectly matched base(s) at or near the ligation junction. Therefore, a mutation outside the target region will not be detected, and a genotype such as D/S will be typed as A/S (Table 2) . (Indeed, the D allele has the normal sequence at codon 6.) Another limitation of LCR is that a negative result indicates the presence of a mismatch but does not reveal its nature. For example, because the C and G San Jose mutations occur near the ligation junction, neither allele should be detected in the A-and S-specific LCRs. Consistent with this prediction, only the S and A alleles were detected in the heterozygous S/C and A/G San Jose samples, respectively; however, the A:S signal ratios obtained differed from those of "true" A/A and S/A samples ( Table 2 ). More samples that are "hemizygous" for the A and S sequences at the LCR target region need to be tested to determine whether this difference is real.
One solution to these limitations of the LCR assay would be to type for all known alleles. The LCR assay is "modular" in the sense that the presence of an allele other than A or S can be determined by simply adding the appropriate allele-specific reaction to the assay. For example, we have designed a C allele-specific LCR that, when performed with the A-and S-specific reactions described here, accurately types samples with respect to the A, S, and C alleles, i.e., A/A, A/S, A/C, S/C, or S/S genotype (data not shown).
In perspective, LCR cannot replace conventional (non-DNA) screening methods for hemoglobin disorders. HPLC can provide information on the presence and abundance of abnormal hemoglobins [4, 14] , whereas LCR is more appropriate for confirmatory diagnosis of suspected mutations by virtue of its highly specific capability for mutation detection. Although in theory a condition such as S/␤ ϩ -thalassemia that is detectable by HPLC [14] would be detectable by LCR, using LCR for this would be impractical because of the large number of possible mutations responsible for the ␤ ϩ -thalassemia phenotype.
In conclusion, we have demonstrated that LCR is an exquisitely specific method for mutation detection. The basic format of the assay described here should be applicable to other genetic diseases of known etiology.
